Search - tctmd.com

Displaying 361 - 380 of 626

Sort: Relevancy | Date

Presentation The Structural Heart Disease Summit 2018

Will the Randomized Trials of MitraClip in Secondary MR Show Substantial Clinical Benefit? YES!

Presenter: Scott Lim

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Will the Randomized Trials of MitraClip in Secondary MR Show Substantial Clinical Benefit? NO!

Presenter: Francesco Maisano

June 22, 2018

News Conference News The Structural Heart Disease Summit 2018

Data or Money: What’s Holding Back Cerebral Embolic Protection in TAVR?

Shelley Wood

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Trialign Pioneering Work: Technology and Clinical Updates

Presenter: Christopher U. Meduri

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

MitraClip Updates I: Recent Clinical Trial Data and Current OUS Patient Selection Criteria

Presenter: Anthony N. DeMaria, Karl-Heinz Kuck, Anita Asgar

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

NOTION 1 - Five-Year FU and Notion 2 - Young & Low-Risk

Presenter: Lars Sondergaard

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

UK All-Comers

Presenter: Neil E. Moat

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Evolut R Low-Risk

Presenter: Jeffrey J. Popma

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Partner 3 Low-Risk

Presenter: Martin B. Leon

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Keystone TRIGUARD Cerebral Embolic Protection During TAVR: New Generation Devices and the Status of Ongoing Clinical Trials

Presenter: Eberhard Grube, Tamim Nazif

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Pharmacotherapy Considerations Trials and Practical Clinical Recommendations

Presenter: George D. Dangas

June 21, 2018

News Daily News

Leaflet Thrombosis After TAVR Not Linked With Stroke, TIA, or Mortality Risk

Michael O'Riordan

June 20, 2018

News Daily News

All-Cause Death Not Increased With Febuxostat Among Medicare Patients With Gout

Caitlin E. Cox

June 19, 2018

News Daily News

Controversial Trial of Alcohol’s ‘Benefits’ for Preventing CVD Halted by NIH

Shelley Wood

June 19, 2018

News Daily News

Reduction in CVD Events, Even Mortality, in Patients With Diabetes Who Adopt a Healthier Lifestyle

Michael O'Riordan

June 18, 2018

News Daily News

Percutaneous Edge-to-Edge Repair for Tricuspid Regurgitation: Some Successes, Some Caveats

Shelley Wood

June 18, 2018

News Daily News

Serial CTA Shines a Light on Statin Effects in Subclinical CAD

Yael L. Maxwell

June 15, 2018

News Featured Fellow

Surbhi Chamaria, MD

Yael L. Maxwell

June 15, 2018

News Daily News

FDA Advisory Panel Gives Thumbs Up to EVAR System

Todd Neale

June 14, 2018

News Daily News

The Patient Presenting With Chest Pain: Stress Echo Gives Coronary CTA a Run for Its Money

Yael L. Maxwell

June 14, 2018

Advertisement

Will the Randomized Trials of MitraClip in Secondary MR Show Substantial Clinical Benefit? YES!

Will the Randomized Trials of MitraClip in Secondary MR Show Substantial Clinical Benefit? NO!

Data or Money: What’s Holding Back Cerebral Embolic Protection in TAVR?

Trialign Pioneering Work: Technology and Clinical Updates

MitraClip Updates I: Recent Clinical Trial Data and Current OUS Patient Selection Criteria

NOTION 1 - Five-Year FU and Notion 2 - Young & Low-Risk

UK All-Comers

Evolut R Low-Risk

Partner 3 Low-Risk

Keystone TRIGUARD Cerebral Embolic Protection During TAVR: New Generation Devices and the Status of Ongoing Clinical Trials

Pharmacotherapy Considerations Trials and Practical Clinical Recommendations

Leaflet Thrombosis After TAVR Not Linked With Stroke, TIA, or Mortality Risk

All-Cause Death Not Increased With Febuxostat Among Medicare Patients With Gout

Controversial Trial of Alcohol’s ‘Benefits’ for Preventing CVD Halted by NIH

Reduction in CVD Events, Even Mortality, in Patients With Diabetes Who Adopt a Healthier Lifestyle

Percutaneous Edge-to-Edge Repair for Tricuspid Regurgitation: Some Successes, Some Caveats

Serial CTA Shines a Light on Statin Effects in Subclinical CAD

Surbhi Chamaria, MD

FDA Advisory Panel Gives Thumbs Up to EVAR System

The Patient Presenting With Chest Pain: Stress Echo Gives Coronary CTA a Run for Its Money

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content